ArticleOncotarget2016
Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein.
Xiansheng Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it